| 0 (0%) | 11-30 07:31 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 163.99 | 1-year : | 191.55 |
| Resists | First : | 140.41 | Second : | 163.99 |
| Pivot price | 130.16  |
|||
| Supports | First : | 126.64 | Second : | 118.13 |
| MAs | MA(5) : | 134.79 |
MA(20) : | 128.25 |
| MA(100) : | 114.98 |
MA(250) : | 106.89 |
|
| MACD | MACD : | 3.4 |
Signal : | 2.5 |
| %K %D | K(14,3) : | 82.4 |
D(3) : | 85.9 |
| RSI | RSI(14): 67 |
|||
| 52-week | High : | 140.41 | Low : | 89.13 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ NHC ] has closed below upper band by 12.6%. Bollinger Bands are 40.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 140.52 - 141.23 | 141.23 - 141.69 |
| Low: | 135.23 - 136.17 | 136.17 - 136.77 |
| Close: | 135.84 - 137.25 | 137.25 - 138.15 |
Sat, 29 Nov 2025
Should Executive Changes and Insider Selling at National HealthCare (NHC) Prompt Investors to Reevaluate Their Outlook? - simplywall.st
Sat, 29 Nov 2025
Liquidity Mapping Around (NHC) Price Events - news.stocktradersdaily.com
Sat, 29 Nov 2025
National HealthCare Co. $NHC Stake Increased by Geode Capital Management LLC - MarketBeat
Thu, 27 Nov 2025
Optimise cross-coupling with ligand-free NHC–Pd precatalysts - Chemistry World
Mon, 17 Nov 2025
Rep. Ted Davis to retire at end of current term, NHC Commissioner Scalise plans run for the seat - WECT
Thu, 13 Nov 2025
History professor selected as a member of NHC Teacher Advisory Council - The Baylor Lariat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 16 (M) |
| Shares Float | 12 (M) |
| Held by Insiders | 18.8 (%) |
| Held by Institutions | 59.3 (%) |
| Shares Short | 256 (K) |
| Shares Short P.Month | 287 (K) |
| EPS | 6.71 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 65.93 |
| Profit Margin | 7.1 % |
| Operating Margin | 9 % |
| Return on Assets (ttm) | 5 % |
| Return on Equity (ttm) | 10.6 % |
| Qtrly Rev. Growth | 28.7 % |
| Gross Profit (p.s.) | 35.85 |
| Sales Per Share | 94.19 |
| EBITDA (p.s.) | 10.36 |
| Qtrly Earnings Growth | -12.2 % |
| Operating Cash Flow | 149 (M) |
| Levered Free Cash Flow | 100 (M) |
| PE Ratio | 20.31 |
| PEG Ratio | 0 |
| Price to Book value | 2.06 |
| Price to Sales | 1.44 |
| Price to Cash Flow | 14.17 |
| Dividend | 0.63 |
| Forward Dividend | 0 |
| Dividend Yield | 0.4% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|